Bifogade filer
PDF
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Spotlight DK |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2025-05-15 16:09:23
Copenhagen, Denmark, 15 May 2025 - Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) hereby announces in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, the disclosure of participation by members of Curasight's Board of Directors, Executive Management and team members in the Right Issue 2025 by exercise Curasight TO subscription rights to purchase new shares in the period May 12 - May 14, 2025.
The following is an overview of the transactions relating to participation in the Right Issue 2025:
| Name | Position | Aggregated volume, new shares | Price, DKK |
| Kirsten Drejer | Chair of the Board | 45,000 | 89,100.00 |
| Lars Trolle | Deputy chair of the Board | 81,103 | 160,583.94 |
| Ulrich Krasilnikoff | CEO & CFO, Board member | 1,297,379 | 2,568,810.42 |
| Andreas Kjær | CMO & CSO, Board member | 1,262,626 | 2,499,999.48 |
| Jacob Madsen | Director CMC and co-founder | 26,220 | 51,915.60 |
| Total | 2,712,328 | 5,370,409.44 |